BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Aug 01, 2011
 |  BC Week In Review  |  Company News  |  Deals

Trius, Bayer deal

Trius granted Bayer exclusive rights to antibiotic candidate torezolid in China, Japan, Africa, Latin America, the Middle East, and all other countries in Asia, excluding North and South Korea. Trius will receive $25 million up front and is eligible for up to $69 million in...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >